期刊文献+

帕利哌酮缓释片与阿立哌唑口腔崩解片治疗精神分裂症的对照研究 被引量:3

The Case - control Study of Schizophrenia Treatment Between Paliperidone Extended -release Tablets with Aripiprazole Orally Disintegrating Tablets
原文传递
导出
摘要 目的:对比帕利哌酮缓释片与阿立哌唑口腔崩解片治疗精神分裂症的疗效及安全性。方法:将符合入组标准的69例精神分裂症患者随机分为帕利哌酮缓释片组(研究组)35例及阿立哌唑口腔崩解片组(对照组)34例,在治疗前及第4、8周末,用阳性和阴性症状量表(PANSS)评定疗效,用副反应量表(TESS)评定不良反应。结果:共完成62例,研究组32例,对照组30例。治疗8周末,研究组有效率93.8%,对照组有效率90.0%,2组比较差异无统计学意义(X2=0.29,P:0.667)。2组在治疗第4、8周末时PANSS总分及阳性症状、阴性症状、精神病性症状评分较治疗前均减少(Ps〈0.05)。在治疗4周末时,研究组阴性症状分下降较对照组明显(t=2.20,P=0.032);治疗8周末时,研究组阴性症状分下降也较对照组明显(t=2.08,P=0.042),2组不良反应发生率差异无统计学意义(】【2=1.00,P=0.316)。结论:帕利哌酮缓释片和阿立哌唑口腔崩解片对精神分裂症疗效相当,且帕利哌酮缓释片对阴性症状有较好的疗效。 Objective: To study the efficacy and safety in the treatment of schizophrenia between Paliporidone extended - release tablets and aripiprazole orally disintegrating tablets. Methods: There were 69 eases of schizophrenia patients who accord with the criteria, they were randomized to study group which 35 eases of paliperidone extended - release tablets and control group which 34 cases of aripi- prazole orally disintegrating tablets. Among the pre - treatment,the medication four weeks and eight weeks, the efficacy was evaluated with positive and negative syndrome scale (PANSS), adverse reaction was assessed by Treatment Emergent Symptom Scale(TESS). Results: A total of 62 cases completed which the 32 cases study group and the 30 cases control group. After 8 weeks of treatment, study group effi- cacy was 93.8%, the control group efficacy was 90.0%, the difference was not statistically significant ( X2 = 0.29, P = 0.667). After the medication four weeks and eight weeks , the PANSS scores, positive symptoms scores,negative symptoms scores, psychotic symptoms scores were reduced which compared with pre - treatment( Ps 〈 0.05 =. After the medication four weeks and eight weeks, negative symp- toms scores from the study group decreased more significantly than the control group respectively (t = 2.20, P = 0. 032) (t = 2.08, P = 0.042 ), adverse reaction was no significant difference from two groups ( x2 = 1.00,P =0.316). Conclusion: The efficacy of Paliper- idone extended - release tablets and aripiprazole orally disintegrating tablets for Schizophrenia was fairly, and Paliporidone extended - release tablets to negative symptoms have better effect.
出处 《中国伤残医学》 2015年第17期28-30,共3页 Chinese Journal of Trauma and Disability Medicine
关键词 帕利哌酮缓释片 阿立哌唑口腔崩解片 精神分裂症 Paliperidone extended - release tablets Aripiprazole orally disintegrating tablets Schizophrenia
  • 相关文献

参考文献10

  • 1王旸,曹昱,张艳.帕利哌酮缓释片对精神分裂症疗效及安全性的对照研究[J].精神医学杂志,2009,22(6):415-419. 被引量:91
  • 2陈海燕,陈在余,马爱霞,罗亚琼.帕利哌酮治疗精神分裂症有效性和安全性的Meta分析[J].循证医学,2012,12(6):354-362. 被引量:10
  • 3Basterreche N, Zumaraga M, Arme A, et al. Aripiprazole reverses Paliperidoneinduced Hyperpolactinemia [ J]. Actas Esp Psiquiatr, 2012,40(5) :290 -292.
  • 4Citrome L. A systematic review of meta - analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia[J]. Expert Opin Pharmacother,2012,13( 11 ) :1545 - 1573.
  • 5范肖东,汪向东,于欣,等,译.世界卫生组织.ICD-10精神与行为障碍分类[M].北京:人民卫生出版社,1993.
  • 6何燕玲 张明园.阳性与阴性症状量表(PANSS)及其应用.临床精神医学杂志,1998,7:353-353.
  • 7Fowler JA, Bettinger T L, Argo TR. Paliperidone extendedrelease tablets for the acute and maintenance treatment of schizophrenia [J]. Clin T her, 2008, 30(2) : 231 - 248.
  • 8Jones MP, Nieholl D, Trakas K. Efficacy and tolerability of paliperi- done ER and Other oralatypieal antpsychoties in schizophrenia[ J ]. Int J Clin Pharmaeol Ther,2010,48(6) :383 -399.
  • 9杨国平,吴越,顾君,汤莉,季萍.帕利哌酮缓释片与阿立哌唑治疗首发精神分裂症对照研究[J].中国健康心理学杂志,2013,21(2):185-186. 被引量:14
  • 10Canuso CM,Tuokoz I, S heean JJ, et al. Efficacy and safety of palipefidone extended - release in schizophrenia patients with prom- inent affective symptoms[J]. J Affective Disorder, 2010, 120( 1 -3) :193-199.

二级参考文献50

  • 1Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition[J]. Am J Psychiatry, 2004, 161 (2) : 1 -56.
  • 2Canadian Psychiatric Association. Clinical practice guidelines: treatment of schizophrenia [ J]. Can J Psychiatry, 2005, 50 (1):7-57.
  • 3Grant S, Fitton A. Risperidone: a review of its pharmacology and therapeutic potential in the treatment of schizophrenia[ J ]. Drags, 1994, 48(2) : 253 -273.
  • 4Revill P, Serradell N, Bolos J. Paliperidone: antipsychotie agent treatment of bipolar disorder dual dopamine D2/5 - HT2A receptor antagonist[ J ]. Drugs Future, 2006, 31 (7) : 579 - 584.
  • 5Herbert YM, William VB, Isaax FN, et al. Efficacy and tolerability of oral paliperidone extended- release tablets in the treatment of acute schizophrenia: pooled data from three 6 - week, placebo- controlled studies [ J]. J Clin Psychiatry, 2008, 69(5) : 817 -829.
  • 6Tzimos A, Lramer M, Ford L, et al. A six - week placebo - controlled study on the safety and tolerability of flexible doses of oral paliperidone extended - release tablets in the treatment of schizophrenia in elderly patients [ C ]. 159^th Annual Meeting of the American Psychiatry Association, 2006, 183.
  • 7Kane J, Canas F, Kramer M, et al. Treatment of schizophrenia with paliperidone extended - release tablets : a 6 - week placebo - controlled trial[ J]. Schizophrenia Research, 2007, 90( 1 ) : 147 - 161.
  • 8Lehman AF, Buchanan RW, Dickerson FB, et al. Evidence - based treatment for schizophrenia [ J ]. Psyehiatr Clin North Am, 2003, 26. 939- 954.
  • 9Lindenmayer JP, Khan A. Pharmacological treatment strategies for schizophrenia[J]. Expert Rev Neurother, 2004, 4: 705- 723.
  • 10Miller AL, Craig CS. Combination antipsychotics: pros, cons, and questions[J]. Schizophr Bull, 2002, 28: 105- 109.

共引文献122

同被引文献20

引证文献3

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部